Atlas Trials

Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease

Clinical trial NCT02867800 · COMPLETED

Trial details

NCT number
NCT02867800
Sponsor
Monica Bhatia
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Sickle Cell DiseaseGraft Versus Host Disease
Start date
2016-07-01
Primary completion
2021-12-30
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.